INVO Fertility, Inc. (IVF): debt financing — INVO Bioscience raises $375K in debt and warrant financings from investors and related party

INVO Fertility, Inc.

On Jan 4, 2023, company sold $275,000 in 10% convertible notes (conversion at $0.50) and 5-year warrants for 275k shares at $1.00.
On Dec 29, 2022, company obtained $100,000 demand note from JAG Multi Investments (CFO-related party) and issued warrant for 350k shares at $0.50.
JAG's prior $400k demand notes payment date extended to March 31, 2023; $350k is callable now.
Proceeds from both financings will be used for working capital and general corporate purposes.
Notes and warrants issued in unregistered private placement under Section 4(a)(2) and Rule 506.

item 1.01 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INVO Fertility, Inc. amended loan of $400,000 with JAG Multi Investments LLC maturing March 31, 2023.

Instrument: loan
Principal: $400,000
Counterparty: JAG Multi Investments LLC
Maturity: March 31, 2023
Event: amendment

Exact text from the filing

the date on which JAG can demand payment of principal, fees and any interest under those certain demand promissory previously issued to JAG by the Company for a total of $400,000, of which JAG may demand payment of $350,000 as of the date hereof, be extended to March 31, 2023

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INVO Fertility, Inc. incurred loan of $100,000 with JAG Multi Investments LLC at 10% annual interest.

Instrument: loan
Principal: $100,000
Counterparty: JAG Multi Investments LLC
Rate: 10% annual interest
Event: incurrence

Exact text from the filing

with JAG Multi Investments LLC (“JAG”), a related party to Andrea Goren, our CFO, who is a beneficiary of JAG but does

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INVO Fertility, Inc. entered into Purchase Agreements with accredited investors valued at $275,000 (effective 2023-01-04).

Action: entry
Agreement: equity purchase
Counterparty: accredited investors
Value: $275,000
Effective: 2023-01-04

Exact text from the filing

the Company entered into definitive securities purchase agreements (the “Purchase Agreements”) with accredited investors for their purchase of (i) unsecured convertible notes of the Company in the aggregate original principal amount of $275,000

View on SEC.gov

90 debt financings filed in the last 30 days. Browse all debt financings →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-000632

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.